Cargando…

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns

Detalles Bibliográficos
Autores principales:	Khanes, G, Nazarchuk, L, Maksakova, I, Bakaieva, O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504914/ http://dx.doi.org/10.1186/cc11800

Ejemplares similares

System approach to the diagnosis and treatment of septic arthritis in newborns
por: Khanes, Gennadiy, et al.
Publicado: (2007)

Antibacterial therapy in treatment of newborns with perinatal sepsis
por: Khanes, G, et al.
Publicado: (2012)

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin
por: Kobayashi, T, et al.
Publicado: (2009)

Comparative study between intravenous immunoglobulins and standard treatment in septic patients
por: Hamed, G, et al.
Publicado: (2008)

Effect of intravenous administration of freeze-dried sulfonated human normal immunoglobulin for septic patients
por: Deguchi, Y, et al.
Publicado: (2009)

Early use of immunoglobulin in septic shock
por: Cavazzuti, IC, et al.
Publicado: (2010)

Kinetics of immunoglobulins in septic shock patients
por: Siqueira, C, et al.
Publicado: (2011)

Antipyretics in the emergency department - intravenous paracetamol versus intramuscular diclofenac: a comparative study
por: Purayil, N, et al.
Publicado: (2014)

Low dose immunoglobulin g for treatment of severe sepsis and septic shock
por: Iizuka, Y, et al.
Publicado: (2015)

Changes in procalcitonin and presepsin before and after immunoglobulin administration in septic patients
por: Ikeda, T, et al.
Publicado: (2015)

Intravenous immunoglobulins prevent breakdown of the blood-brain barrier in experimental sepsis
por: Esen, F, et al.
Publicado: (2010)

Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
por: Saladi, SM, et al.
Publicado: (2008)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Use of intravenous immunoglobulin to treat sepsis in a general ICU
por: Drakeford, Y, et al.
Publicado: (2015)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Usefulness of intravenous immunoglobulin administration to sepsis-induced coagulopathy in ICU patients
por: Matsumoto, N, et al.
Publicado: (2014)

Impact of purulent complications and sepsis on cardiovascular system in patients with type 2 diabetes
por: Shalaeva, E, et al.
Publicado: (2014)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Low levels of immunoglobulin G in patients with sepsis or septic shock: a signum mali ominis?
por: Dietz, S, et al.
Publicado: (2010)

Igm-enriched polyclonal immunoglobulins in an experimental model of gram negative pneumonia developing septic shock
por: Vaschetto, R, et al.
Publicado: (2015)

Effect of intravenous immunoglobulin in critically ill adult patients with sepsis: a meta-analysis
por: Turgeon, A, et al.
Publicado: (2006)

Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis
por: Dalm, Virgil, et al.
Publicado: (2013)

Prehospital administered intravenous antimicrobial protocol for septic shock: a prospective randomized clinical trial
por: Chamberlain, D
Publicado: (2009)

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone
por: Goto, Masahiro, et al.
Publicado: (2015)

Outcome in severe sepsis and septic shock patients with hematological malignancies: impact of recent intravenous chemotherapeutic treatment
por: Vandijck, D, et al.
Publicado: (2008)

Early treatment with intravenous immunoglobulins in patients with critical illness polyneuropathy: a randomized controlled, double-blinded study
por: Brunner, R, et al.
Publicado: (2012)

Severity of sepsis in patients with acute purulent destructive pulmonary disease depending on the presence of type 2 diabetes: impact on the forecast
por: Babobekov, A, et al.
Publicado: (2014)

Death from Purulent Infection
Publicado: (1865)

Intravenous immunoglobulin reduces the ischemia/reperfusion-induced renal injury by increasing insulin-like growth factor-I production in mice
por: Harada, N, et al.
Publicado: (2008)

Intra-abdominal hypertension as a risk factor of death in patients with severe sepsis or septic shock
por: Reintam, A, et al.
Publicado: (2007)

Clinical practice of fluid resuscitation in severe sepsis and septic shock on German ICUs
por: Ragaller, M, et al.
Publicado: (2006)

Systemic hemodynamic during continuous hemodiafiltration in patients with septic shock
por: Mouravev, O, et al.
Publicado: (2004)

Prognostic factors of septic shock
por: Quenot, JP, et al.
Publicado: (2012)

Steroid therapy in septic shock: survey of practice amongst UK critical care physicians
por: Rajendran, G, et al.
Publicado: (2013)

IMPACT OF TRIALS ON CLINICAL PRACTICE: INTERVENTIONS IN SEPTIC SHOCK PATIENTS BETWEEN 2005 AND 2013
por: Jones, A, et al.
Publicado: (2015)

Inhaled and intravenous application of a stimulator of the soluble guanylate cyclase (BAY 41-8543) reduces pulmonary vascular resistance in a model of septic shock
por: Kronas, Nils, et al.
Publicado: (2011)

Effect of transfusion, leukocyte-depleted blood product on onset of new septic shock and mortality in septic shock
por: Hayami, H, et al.
Publicado: (2010)

Severe sepsis and septic shock in Croatian ICUs
por: Gornik, I, et al.
Publicado: (2006)

Immunoglobulin therapy of abdominal sepsis in emergency surgery
por: Butyrsky, O, et al.
Publicado: (2012)

Functional protein C levels in septic patients
por: Lafuente, E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_bq4uuip2ks2p82id46tdsrfj9r